The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Zaccardelli David since year 2005.
The trader's CIK number is 1627642.
At the time of the last reporting, Zaccardelli David was the President & CEO of Dova Pharmaceuticals Inc. .
(stock ticker symbol DOVA).
See this page for all insider trading activities at Dova Pharmaceuticals Inc. .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2019-07-02 | DOVA | Dova Pharmaceuticals Inc. | Sale | 10,450 | 15.97 | 166,938 |
| 2018-12-20 | DOVA | Dova Pharmaceuticals Inc. | Buy | 10,000 | 6.07 | 60,700 |
| 2018-05-29 | MLNT | Melinta Therapeutics, Inc. /new/ | Buy | 40,000 | 5.00 | 200,000 |
| 2015-12-29 | UTHR | United Therapeutics Corp | Option Ex | 2,000 | 65.80 | 131,600 |
| 2015-12-22 | UTHR | United Therapeutics Corp | Option Ex | 2,000 | 65.80 | 131,600 |
| 2015-12-15 | UTHR | United Therapeutics Corp | Option Ex | 2,000 | 65.80 | 131,600 |
| 2015-12-08 | UTHR | United Therapeutics Corp | Option Ex | 2,000 | 65.80 | 131,600 |
| 2015-12-01 | UTHR | United Therapeutics Corp | Option Ex | 2,000 | 65.80 | 131,600 |
| 2015-11-24 | UTHR | United Therapeutics Corp | Option Ex | 2,000 | 63.43 | 126,860 |
| 2015-11-17 | UTHR | United Therapeutics Corp | Option Ex | 1,000 | 61.06 | 61,060 |
| 2015-11-10 | UTHR | United Therapeutics Corp | Option Ex | 2,000 | 61.06 | 122,120 |
| 2015-11-03 | UTHR | United Therapeutics Corp | Option Ex | 2,000 | 61.06 | 122,120 |
| 2015-10-27 | UTHR | United Therapeutics Corp | Option Ex | 3,000 | 61.06 | 183,180 |
| 2015-10-06 | UTHR | United Therapeutics Corp | Option Ex | 1,000 | 61.06 | 61,060 |
| 2015-09-29 | UTHR | United Therapeutics Corp | Option Ex | 1,000 | 61.06 | 61,060 |
| 2015-09-22 | UTHR | United Therapeutics Corp | Option Ex | 1,000 | 61.06 | 61,060 |
| 2015-09-15 | UTHR | United Therapeutics Corp | Option Ex | 2,000 | 61.06 | 122,120 |
| 2015-09-08 | UTHR | United Therapeutics Corp | Option Ex | 2,000 | 61.06 | 122,120 |
| 2015-09-01 | UTHR | United Therapeutics Corp | Option Ex | 1,000 | 61.06 | 61,060 |
| 2015-08-25 | UTHR | United Therapeutics Corp | Option Ex | 2,000 | 61.06 | 122,120 |
| 2015-08-18 | UTHR | United Therapeutics Corp | Option Ex | 2,000 | 61.06 | 122,120 |
| 2015-08-11 | UTHR | United Therapeutics Corp | Option Ex | 2,000 | 61.06 | 122,120 |
| 2015-07-21 | UTHR | United Therapeutics Corp | Option Ex | 928 | 57.15 | 53,035 |
| 2015-07-14 | UTHR | United Therapeutics Corp | Option Ex | 4,000 | 57.15 | 228,600 |
| 2015-07-07 | UTHR | United Therapeutics Corp | Option Ex | 2,000 | 57.15 | 114,300 |
| 2015-06-30 | UTHR | United Therapeutics Corp | Option Ex | 2,000 | 57.15 | 114,300 |
| 2015-06-23 | UTHR | United Therapeutics Corp | Option Ex | 4,000 | 57.15 | 228,600 |
| 2015-06-16 | UTHR | United Therapeutics Corp | Option Ex | 4,000 | 57.15 | 228,600 |
| 2015-06-09 | UTHR | United Therapeutics Corp | Option Ex | 4,000 | 57.15 | 228,600 |
| 2015-06-02 | UTHR | United Therapeutics Corp | Option Ex | 4,000 | 57.15 | 228,600 |
| 2015-05-26 | UTHR | United Therapeutics Corp | Option Ex | 4,000 | 57.15 | 228,600 |
| 2015-05-19 | UTHR | United Therapeutics Corp | Option Ex | 4,000 | 57.15 | 228,600 |
| 2015-04-14 | UTHR | United Therapeutics Corp | Option Ex | 3,250 | 51.37 | 166,952 |
| 2015-04-14 | UTHR | United Therapeutics Corp | Sale | 3,250 | 185.82 | 603,915 |
| 2015-04-09 | UTHR | United Therapeutics Corp | Option Ex | 4,000 | 51.37 | 205,480 |
| 2015-04-09 | UTHR | United Therapeutics Corp | Sale | 4,000 | 184.84 | 739,360 |
| 2015-04-07 | UTHR | United Therapeutics Corp | Sale | 4,000 | 179.34 | 717,360 |
| 2015-04-07 | UTHR | United Therapeutics Corp | Option Ex | 4,000 | 51.37 | 205,480 |
| 2015-04-02 | UTHR | United Therapeutics Corp | Option Ex | 4,000 | 51.37 | 205,480 |
| 2015-04-02 | UTHR | United Therapeutics Corp | Sale | 4,000 | 174.73 | 698,920 |
| 2015-03-31 | UTHR | United Therapeutics Corp | Option Ex | 4,000 | 51.37 | 205,480 |
| 2015-03-31 | UTHR | United Therapeutics Corp | Sale | 4,000 | 172.44 | 689,740 |
| 2015-03-26 | UTHR | United Therapeutics Corp | Option Ex | 4,000 | 51.37 | 205,480 |
| 2015-03-26 | UTHR | United Therapeutics Corp | Sale | 4,000 | 167.52 | 670,080 |
| 2015-03-24 | UTHR | United Therapeutics Corp | Sale | 4,500 | 179.51 | 807,795 |
| 2015-03-24 | UTHR | United Therapeutics Corp | Option Ex | 4,500 | 49.44 | 222,457 |
| 2015-03-19 | UTHR | United Therapeutics Corp | Option Ex | 4,000 | 47.50 | 190,000 |
| 2015-03-19 | UTHR | United Therapeutics Corp | Sale | 4,000 | 175.82 | 703,280 |
| 2015-03-17 | UTHR | United Therapeutics Corp | Sale | 4,000 | 177.34 | 709,360 |
| 2015-03-17 | UTHR | United Therapeutics Corp | Option Ex | 4,000 | 47.50 | 190,000 |
| 2015-02-24 | UTHR | United Therapeutics Corp | Option Ex | 1,458 | 50.09 | 73,031 |
| 2015-02-24 | UTHR | United Therapeutics Corp | Sale | 1,458 | 155.16 | 226,223 |
| 2015-02-17 | UTHR | United Therapeutics Corp | Option Ex | 4,000 | 50.09 | 200,360 |
| 2015-02-17 | UTHR | United Therapeutics Corp | Sale | 4,000 | 155.14 | 620,560 |
| 2015-02-10 | UTHR | United Therapeutics Corp | Option Ex | 4,000 | 50.09 | 200,360 |
| 2015-02-10 | UTHR | United Therapeutics Corp | Sale | 4,000 | 146.68 | 586,720 |
| 2015-02-03 | UTHR | United Therapeutics Corp | Option Ex | 4,000 | 50.09 | 200,360 |
| 2015-02-03 | UTHR | United Therapeutics Corp | Sale | 4,000 | 141.99 | 567,960 |
| 2015-01-27 | UTHR | United Therapeutics Corp | Option Ex | 4,000 | 50.09 | 200,360 |
| 2015-01-27 | UTHR | United Therapeutics Corp | Sale | 4,000 | 147.19 | 588,760 |
| 2015-01-20 | UTHR | United Therapeutics Corp | Option Ex | 4,000 | 50.09 | 200,360 |
| 2015-01-20 | UTHR | United Therapeutics Corp | Sale | 4,000 | 146.48 | 585,920 |
| 2015-01-13 | UTHR | United Therapeutics Corp | Option Ex | 3,000 | 50.09 | 150,270 |
| 2015-01-13 | UTHR | United Therapeutics Corp | Sale | 3,000 | 134.71 | 404,130 |
| 2015-01-06 | UTHR | United Therapeutics Corp | Sale | 3,000 | 124.93 | 374,790 |
| 2015-01-06 | UTHR | United Therapeutics Corp | Option Ex | 3,000 | 48.80 | 146,385 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Zaccardelli David (President & CEO of Dova Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.